Smoldering myeloma: Difference between revisions
From IDWiki
(Imported from text file) Â |
(→â€)  |
||
Line 1: | Line 1: | ||
== |
==Definition== |
||
* |
*M-spike ≥30 g/L or UPEP ≥500 mg/24h, and/or |
||
* |
*Bone marrow plasma cells 10-60%, and |
||
* |
*No end-organ damage |
||
== |
== Management == |
||
⚫ | |||
* Monitoring |
|||
==Prognosis== |
|||
⚫ | |||
[[Category:Hematology]] |
[[Category:Hematology]] |
Latest revision as of 20:05, 2 August 2020
Definition
- M-spike ≥30 g/L or UPEP ≥500 mg/24h, and/or
- Bone marrow plasma cells 10-60%, and
- No end-organ damage
Management
- Monitoring
Prognosis
- About 10% per year will progress to multiple myeloma